Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Standard Biotools (LAB) Cost of Revenue (2016 - 2026)

Standard Biotools has reported Cost of Revenue over the past 16 years, most recently at $12.4 million for Q4 2025.

  • Quarterly Cost of Revenue fell 7.5% to $12.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $54.7 million through Dec 2025, down 3.84% year-over-year, with the annual reading at $42.8 million for FY2025, 7.23% down from the prior year.
  • Cost of Revenue was $12.4 million for Q4 2025 at Standard Biotools, up from $10.1 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $21.4 million in Q1 2024 and troughed at $1.5 million in Q3 2021.
  • The 5-year median for Cost of Revenue is $12.8 million (2023), against an average of $11.7 million.
  • Year-over-year, Cost of Revenue plummeted 78.32% in 2021 and then soared 989.26% in 2022.
  • A 5-year view of Cost of Revenue shows it stood at $1.5 million in 2021, then surged by 951.33% to $15.9 million in 2022, then dropped by 6.45% to $14.8 million in 2023, then decreased by 9.51% to $13.4 million in 2024, then dropped by 7.5% to $12.4 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Cost of Revenue are $12.4 million (Q4 2025), $10.1 million (Q3 2025), and $11.1 million (Q2 2025).